Pharmacare 2013, held in Ottawa, Canada, attracted a wide range of Canadian experts, senior government managers, health policy analysts, health practitioners and professionals, academics, policy makers, unions, elected government officials, students, and the public. Pharmaceutical and health care policy experts from New Zealand, United Kingdom, and France were also in attendance. Generic and brand-name drug industry representatives were also in attendance and contributed to the dialogue.
All of these representatives came together to build political momentum and discuss and debate strategies for implementing a national pharmacare program to afford all Canadians with equitable access to essential prescription medications, to be identified and listed on a national drug formulary. Implementing a national pharmacare strategy would control costs of prescription medications by allowing a unified provider to negotiate drug costs with the respective drug companies and reduce the costs associated with having an administrative system fragmented by individual provinces bearing the burden of individually negotiating confidential pricing contracts for drugs with each company. A national pharmacare program would also improve not only drug safety and monitoring, but also physicians' prescribing practices.
Currently, all developed countries globally that have universal health care systems, as does Canada, provides universal coverage for prescription drugs - except Canada. Canada can afford a such a program. Pharmacare would allow Canadians, who already pay out-of-pocket or through private insurance for prescription drugs, to pay more effectively, economically, and fairly.
View the Pharmacare 2013 website here: http://pharmacare2013.ca/
View the Pharmacare 2013 agenda here: http://pharmacare2013.ca/agenda/
View the Pharmacare 2013 speakers here: http://pharmacare2013.ca/speaker-biographies/